Bayard L. Powell, MD
- Professor, Hematology and Oncology

Bayard L. Powell, MD
Research Interests
- Clinical Research in Acute Leukemia
- Chronic Leukemia
- Myelodysplastic Syndrome
- Education
- BSE, Duke University, 1976
- MD, University of North Carolina at Chapel Hill School of Medicine, 1980
- Residency
- Wake Forest Baptist Medical Center, 1983
- Board Certifications
- American Board of Internal Medicine, Internal Medicine
- American Board of Internal Medicine, Medical Oncology
- Memberships
- American College of Physicians
- Cancer and Acute Leukemia Group B.
- American Society of Hematology
- American Society of Clinical Oncology
- Association of Med Schl Professors of Psycholgy
- Positions
- Section Chief, Hematology and Oncology
- Medical Director for Medical Oncology, Hematology and Oncology
- Professor, Hematology and Oncology
- Departments and Affiliations
- Hematology and Oncology
- Comprehensive Cancer Center
Research
- Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia. Walker CJ, Kohlschmidt J, Eisfeld AK, Mrózek K, Liyanarachchi S, Song C, Nicolet D, Blachly JS, Bill M, Papaioannou D, Oakes CC, Giacopelli B, Genutis LK, Maharry SE, Orwick S, Archer KJ, Powell BL, Kolitz JE, Uy GL, Wang ES, Carroll AJ, Stone RM, Byrd JC, de la Chapelle A, Bloomfield CD. Clin. Cancer Res. 2019 11; 25(21):6524-6531.
- Goals and Adverse Effects: Rate of Concordance Between Patients and Providers. Duckworth KE, Morrell R, Russell GB, Powell B, Canzona M, Lichiello S, Riffle O, Tolbert A, McQuellon R. J Oncol Pract. 2019 09; 15(9):e798-e806.
- Inflammatory biomarkers, geriatric assessment, and treatment outcomes in acute myeloid leukemia. Loh KP, Tooze JA, Nicklas BJ, Kritchevsky SB, Williamson JD, Ellis LR, Powell BL, Pardee TS, Goyal NG, Klepin HD. J Geriatr Oncol. 2020 04; 11(3):410-416.
- Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinically. Mrózek K, Eisfeld AK, Kohlschmidt J, Carroll AJ, Walker CJ, Nicolet D, Blachly JS, Bill M, Papaioannou D, Wang ES, Uy GL, Kolitz JE, Powell BL, Blum W, Stone RM, Byrd JC, Bloomfield CD. Leukemia. 2019 07; 33(7):1620-1634.
- Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance). Roboz GJ, Mandrekar SJ, Desai P, Laumann K, Walker AR, Wang ES, Kolitz JE, Powell BL, Attar EC, Stock W, Bloomfield CD, Kohlschmidt J, Mrózek K, Hassane DC, Garraway L, Jané-Valbuena J, Baltay M, Tracy A, Marcucci G, Stone RM, Larson RA. Blood Adv. 2018 12; 2(24):3608-3617.